Top Clinical Trials Startups in 2026

TrialSpark is transforming the way new medical treatments are brought to market. We’re a technology company that runs end-to-end clinical trials through a network of our own TrialSpark-operated trial sites, making the entire lifecycle of clinical trials more efficient, accessible, and patient-centric. We're growing quickly and would love to have you join us!

As population continues to age, there is a growing demand for motor rehabilitation services. The problem is that the way we address this growth or rehabilitation services (physical therapy) has not changed in thirty years because we are still heavily reliant on a one-to-one patient therapist interaction which is costly, non scalable, and difficult to ensure consistent quality. At SWORD Health, we saw the opportunity to take a truly disruptive and transformative approach to this problem by creating the first digital therapy solution that addresses the growing demand for therapy while reducing costs, empowering patients with their recovery to ultimately recover faster, and providing a rich source of data for clinical teams and decision makers. Video: vimeo.com/118489111

Triomics is revolutionizing the process of data management for clinical research by leveraging EHR interoperability and machine learning.

PicnicAI deploys AI into the real-world complexity of care delivery and clinical research. PicnicHealth helps patients navigate fragmented care with AI-powered tools backed by a clinical team, giving them a unified view of their health across all their doctors. PicnicResearch makes clinical research faster, cheaper, and more reliable, using AI agents and direct patient relationships to change the economics of drug development so that more treatments reach the patients who need them.

Tempus is a technology company that has built an operating system to battle cancer. Tempus enables physicians to deliver personalized cancer care through its interactive analytical and machine learning platform. The company provides genomic sequencing services and analyzes molecular and therapeutic data to empower physicians to make real-time, data-driven decisions. Our goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as we gather more data.

James Lind pioneered the first clinical trial in the 18th century, using oranges and lemons as a cure for scurvy. Like Lind, our mission is to improve health outcomes for all. Today clinical trials are slow, inefficient and hugely expensive. The result is that patients lose out on new treatments. Lindus Health will fix this. We're building the platform for the next generation of clinical trials.

Altis Labs is the AI-powered computational imaging company advancing precision medicine. Trained on the world's largest cancer imaging database, our deep learning models predict outcomes to quantify treatment effect more accurately. Leading biopharmaceutical companies use our AI platform, Nota, to analyze clinical trial imaging data in a more meaningful way, allowing them to develop effective novel therapies faster. Founded in 2019, Altis is a venture-backed company headquartered in Toronto. We are actively growing our team in Canada and the US across functional areas.

Auxilius is a data-driven, clinical trial financial management platform. We help Biotechs take control over trial costs, manage financial risk, and optimize spend in pursuit of trial targets.

Reify Health provides cloud-based software that accelerates development of new and life-saving therapies. We serve the global life science industry, including thousands of clinical research sites, the most innovative biotechs, and the world’s largest biopharmaceutical companies. Our global healthcare system relies on clinical trials to develop new, life-saving treatments for patients. But clinical trials continue to be slow, unpredictable, and expensive. Reify Health’s StudyTeam clinical trial software empowers both the research sponsors who drive clinical trials forward and the doctors and research coordinators who care for patient volunteers so that they can devote more focus and time toward the work that results in successful clinical research.

RDI is an overnight success — years in the making. We’re scaling fast (grew 4× last year), fueled by enterprise engagements with the top IVD manufacturers in the world. For a small team, we punch way above our weight. RDI has become the go-to CRO for large public diagnostics companies who rely on our creativity, tech-forward systems, and zero-excuses accountability to get trials done quickly and done right. We’re a fully integrated IVD CRO — a high-complexity CLIA lab, a technology-enabled CRO, and a national physician + lab network under one roof. This lets us run clinical trials with a level of speed and operational precision the industry isn’t used to. RDI was founded in 2008 and professionalized in 2017 through a search fund acquisition (not venture hype). We’re backed by long-term operators and growth investors — not dependent on VC burn or fundraising cycles. From 2022–2024, we expanded aggressively by doing the hard things right: building real infrastructure, earning trust from enterprise customers, and executing consistently. Our physician network was sourced from real insurance claims data and strengthened by CAP accreditation. No one has successfully started and scaled a modern CRO focused on diagnostics and medical devices in over 15 years. The industry is dominated by large, slow incumbents optimized for pharma — not speed, accountability, or precision. We’re the underdog — and we’re winning. Our goal is simple: prove our customers right, and prove the industry wrong. Get a feel for how we work: youtube.com/watch?v=3tccEbsWIl8